STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Praxis Precision Medicines to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Praxis Precision Medicines (NASDAQ: PRAX) has announced its participation in two upcoming virtual investor conferences. The RBC Capital Markets Global Healthcare Conference presentation is scheduled for May 19, 2021, at 2:30 p.m. ET. Additionally, a prerecorded presentation at the Oppenheimer Rare & Orphan Disease Summit will be available on May 21, 2021, at 8:00 a.m. ET. Both events can be accessed via the company's website, and replays will be available for 90 days.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., May 14, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance, today announced that management will participate in the following upcoming virtual investor conferences:

  • RBC Capital Markets Global Healthcare Conference
    Presentation on Wednesday, May 19, 2021 at 2:30 p.m. ET
  • Oppenheimer Rare & Orphan Disease Summit
    Prerecorded presentation available on Friday, May 21, 2021 at 8:00 a.m. ET

The events will be available via webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. Replays of the webcasts will be available for 90 days following the events.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights from genetic epilepsies to broader neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio, including multiple disclosed programs across CNS disorders including depression, epilepsy, movement disorders and pain syndromes, with three clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.


FAQ

What are the dates for Praxis Precision Medicines' investor conferences?

Praxis Precision Medicines will present at the RBC Capital Markets Global Healthcare Conference on May 19, 2021, and at the Oppenheimer Rare & Orphan Disease Summit on May 21, 2021.

How can I watch the Praxis Precision Medicines presentations?

The presentations will be available via webcast on the Events & Presentations page of the company's website.

What time is the RBC Capital Markets Global Healthcare Conference presentation by Praxis?

The presentation is scheduled for May 19, 2021, at 2:30 p.m. ET.

When will the prerecorded presentation for the Oppenheimer Rare & Orphan Disease Summit be available?

The prerecorded presentation will be accessible on May 21, 2021, at 8:00 a.m. ET.

How long will the webcasts for Praxis' presentations be available?

Replays of the webcasts will be available for 90 days after the events.

Praxis Precision Medicines, Inc.

NASDAQ:PRAX

PRAX Rankings

PRAX Latest News

PRAX Stock Data

1.48B
17.35M
0.25%
104.05%
9.7%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOSTON